TENBORON’S LEAD MOLECULE ENTERS CLINICAL STAGE
The Finnish Medicines Agency Fimea has approved Tenboron’s Phase I clinical trial application.The study will be conducted at the Helsinki University Hospital.Preparations for study initiation are underway.